InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 09/06/2017 8:05:05 AM

Wednesday, September 06, 2017 8:05:05 AM

Post# of 27623
CBIO - 3.39 Pre-market now at 3.80/3.90

BZ: Catalyst Biosciences Reports Factor IX Data: 'CB 2679d/ISU304 is approximately 22 times more potent than current hemophilia B therapy'

Catalyst Biosciences Announces Positive Factor IX Clinical Data



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.